Radoff-JEC Group Raises Takeover Bid to $2.35 per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy SEER?
Source: seekingalpha
- Increased Offer: The Radoff-JEC Group has raised its unsolicited takeover bid for Seer to $2.35 per share, representing a 39% premium over the stock's closing price on April 10, indicating strong confidence in Seer's future value.
- Contingent Value Rights: The revised proposal includes a structure where Seer shareholders would receive 80% of the net proceeds from asset sales through contingent value rights, enhancing the attractiveness of the acquisition for shareholders.
- Investment Commitment: Radoff-JEC has also expressed readiness to invest $10 million in Seer, demonstrating support for the company's business development while criticizing the board for not engaging with its earlier acquisition proposal.
- Shareholder Support: The activist group collectively owns about 7.6% of Seer's outstanding shares, and the revised offer will expire if the board does not respond by May 2, applying pressure on the board's decision-making process.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SEER?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SEER
About SEER
Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Radoff-JEC Group Raises Takeover Bid to $2.35 per Share
- Increased Offer: The Radoff-JEC Group has raised its unsolicited takeover bid for Seer to $2.35 per share, representing a 39% premium over the stock's closing price on April 10, indicating strong confidence in Seer's future value.
- Contingent Value Rights: The revised proposal includes a structure where Seer shareholders would receive 80% of the net proceeds from asset sales through contingent value rights, enhancing the attractiveness of the acquisition for shareholders.
- Investment Commitment: Radoff-JEC has also expressed readiness to invest $10 million in Seer, demonstrating support for the company's business development while criticizing the board for not engaging with its earlier acquisition proposal.
- Shareholder Support: The activist group collectively owns about 7.6% of Seer's outstanding shares, and the revised offer will expire if the board does not respond by May 2, applying pressure on the board's decision-making process.
See More
Radoff-JEC Group Proposes Acquisition of Seer at $2.35 per Share
- Acquisition Proposal Overview: The Radoff-JEC Group has proposed to acquire Seer at $2.35 per share in cash, representing a 39% premium to the unaffected closing price, while also offering additional rights related to asset disposition, aiming to provide immediate value to shareholders and prevent further value erosion.
- Critique of Operating Performance: Seer's stock price has plummeted over 90% since its IPO, with cumulative losses exceeding $465 million and virtually no revenue growth, indicating a failure of the current leadership to effectively navigate market competition and resulting in significant shareholder value destruction.
- Industry Comparison Analysis: In contrast to successful companies like Alamar Biosciences, Seer has failed to achieve revenue growth over the past five years, highlighting its lack of competitiveness in the industry and a bleak outlook for the future.
- Proposal Execution Readiness: The Radoff-JEC Group is prepared to provide $215 million in cash and cash equivalents to support the acquisition and aims to complete due diligence and negotiate a merger agreement by May 18, 2026, demonstrating their strong commitment to the acquisition process.
See More
Seer, Inc. Receives Acquisition Proposal
- Acquisition Proposal Confirmation: Seer, Inc. has confirmed receipt of a non-binding acquisition proposal from the Radoff-JEC Group, offering $2.25 per share in cash plus a contingent value right, indicating market interest in the company's future potential.
- Board Review: The Seer Board will carefully review the proposal in consultation with independent financial and legal advisors to ensure actions align with the best interests of the company and its shareholders, reflecting the company's commitment to governance.
- Director Nominations: The Radoff-JEC Group has nominated three director candidates for the 2026 Annual Meeting, with the Board set to review these nominations according to company bylaws, highlighting shareholder influence on corporate governance.
- Proxy Statement Preparation: Seer plans to file a definitive proxy statement with the SEC detailing the Board's formal recommendations regarding the nominations, ensuring all shareholders have adequate information to make informed voting decisions at the Annual Meeting.
See More
Activist Investors Bid to Acquire Seer, Inc. at $2.25 per Share
- Acquisition Proposal: The Radoff-JEC Group has launched a bid to acquire Seer, Inc. at $2.25 per share in cash, representing a 33% premium over the recent closing price, reflecting strong confidence in the company's future value.
- Shareholder Rights Assurance: The acquisition offer includes a Contingent Value Right (CVR) that guarantees shareholders 80% of net proceeds from any future sale or licensing of Seer's assets, enhancing investor expectations for long-term returns.
- Financial Conditions: The proposal is not subject to any financing conditions and promises a substantial non-performance fee to ensure the Board's ability to close the deal, while requiring Seer to maintain at least $215 million in net cash at closing.
- Management Critique: The Radoff-JEC Group sharply criticized the current CEO's performance in their letter, highlighting that $160 million in capital investment has yielded negligible revenue growth, warning that the projected $40 million cash burn in 2026 is unsustainable for shareholders.
See More
SEER INC: PATENT BOARD AFFIRMS SEER'S NANO AND MICRO PARTICLE PROTEIN ENRICHMENT PATENT AGAINST BRUKER SUBSIDIARIES' CHALLENGE
Patent Board Decision: The Patent Board has upheld Seer's patent related to nano and microparticle protein enrichment.
Challenge by Bruker: This decision comes in response to a challenge posed by Bruker Subsidiaries regarding the validity of Seer's patent.
See More
RADOFF-JEC GROUP URGES SEER BOARD TO INITIATE SALE PROCESS
- Announcement of Sale Process: The Radoff-Jec Group has called on the Seer Board to announce a sale process for the company.
- Strategic Move: This move is seen as a strategic step to enhance shareholder value and attract potential buyers.
See More
Radoff-JEC Group Raises Takeover Bid to $2.35 per Share
- Increased Offer: The Radoff-JEC Group has raised its unsolicited takeover bid for Seer to $2.35 per share, representing a 39% premium over the stock's closing price on April 10, indicating strong confidence in Seer's future value.
- Contingent Value Rights: The revised proposal includes a structure where Seer shareholders would receive 80% of the net proceeds from asset sales through contingent value rights, enhancing the attractiveness of the acquisition for shareholders.
- Investment Commitment: Radoff-JEC has also expressed readiness to invest $10 million in Seer, demonstrating support for the company's business development while criticizing the board for not engaging with its earlier acquisition proposal.
- Shareholder Support: The activist group collectively owns about 7.6% of Seer's outstanding shares, and the revised offer will expire if the board does not respond by May 2, applying pressure on the board's decision-making process.
See More
Radoff-JEC Group Proposes Acquisition of Seer at $2.35 per Share
- Acquisition Proposal Overview: The Radoff-JEC Group has proposed to acquire Seer at $2.35 per share in cash, representing a 39% premium to the unaffected closing price, while also offering additional rights related to asset disposition, aiming to provide immediate value to shareholders and prevent further value erosion.
- Critique of Operating Performance: Seer's stock price has plummeted over 90% since its IPO, with cumulative losses exceeding $465 million and virtually no revenue growth, indicating a failure of the current leadership to effectively navigate market competition and resulting in significant shareholder value destruction.
- Industry Comparison Analysis: In contrast to successful companies like Alamar Biosciences, Seer has failed to achieve revenue growth over the past five years, highlighting its lack of competitiveness in the industry and a bleak outlook for the future.
- Proposal Execution Readiness: The Radoff-JEC Group is prepared to provide $215 million in cash and cash equivalents to support the acquisition and aims to complete due diligence and negotiate a merger agreement by May 18, 2026, demonstrating their strong commitment to the acquisition process.
See More
Seer, Inc. Receives Acquisition Proposal
- Acquisition Proposal Confirmation: Seer, Inc. has confirmed receipt of a non-binding acquisition proposal from the Radoff-JEC Group, offering $2.25 per share in cash plus a contingent value right, indicating market interest in the company's future potential.
- Board Review: The Seer Board will carefully review the proposal in consultation with independent financial and legal advisors to ensure actions align with the best interests of the company and its shareholders, reflecting the company's commitment to governance.
- Director Nominations: The Radoff-JEC Group has nominated three director candidates for the 2026 Annual Meeting, with the Board set to review these nominations according to company bylaws, highlighting shareholder influence on corporate governance.
- Proxy Statement Preparation: Seer plans to file a definitive proxy statement with the SEC detailing the Board's formal recommendations regarding the nominations, ensuring all shareholders have adequate information to make informed voting decisions at the Annual Meeting.
See More
Activist Investors Bid to Acquire Seer, Inc. at $2.25 per Share
- Acquisition Proposal: The Radoff-JEC Group has launched a bid to acquire Seer, Inc. at $2.25 per share in cash, representing a 33% premium over the recent closing price, reflecting strong confidence in the company's future value.
- Shareholder Rights Assurance: The acquisition offer includes a Contingent Value Right (CVR) that guarantees shareholders 80% of net proceeds from any future sale or licensing of Seer's assets, enhancing investor expectations for long-term returns.
- Financial Conditions: The proposal is not subject to any financing conditions and promises a substantial non-performance fee to ensure the Board's ability to close the deal, while requiring Seer to maintain at least $215 million in net cash at closing.
- Management Critique: The Radoff-JEC Group sharply criticized the current CEO's performance in their letter, highlighting that $160 million in capital investment has yielded negligible revenue growth, warning that the projected $40 million cash burn in 2026 is unsustainable for shareholders.
See More
SEER INC: PATENT BOARD AFFIRMS SEER'S NANO AND MICRO PARTICLE PROTEIN ENRICHMENT PATENT AGAINST BRUKER SUBSIDIARIES' CHALLENGE
Patent Board Decision: The Patent Board has upheld Seer's patent related to nano and microparticle protein enrichment.
Challenge by Bruker: This decision comes in response to a challenge posed by Bruker Subsidiaries regarding the validity of Seer's patent.
See More
RADOFF-JEC GROUP URGES SEER BOARD TO INITIATE SALE PROCESS
- Announcement of Sale Process: The Radoff-Jec Group has called on the Seer Board to announce a sale process for the company.
- Strategic Move: This move is seen as a strategic step to enhance shareholder value and attract potential buyers.
See More
